<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046745"><TermName>17-N-allylamino-17-demethoxygeldanamycin</TermName><TermPronunciation>(17-N-A-lul-uh-MEE-noh-17-DEE-meh-THOK-see-gel-DA-nuh-MY-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710021" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;17-N-allylamino-17-demethoxygeldanamycin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710022" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;17-N-alilamino-17-demetoxigeldanamicina&quot;" language="es" id="_4"/><SpanishTermName>17-N-alilamino-17-demetoxigeldanamicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Está elaborado con un antibiótico que se llama geldanamicina. 17-N-alilamino-17-demetoxigeldanamicina ayuda a descomponer ciertas proteínas de la célula y podría destruir células cancerosas. Es un tipo de antibiótico antineoplásico y un tipo de inhibidor de la HSP90. También se llama 17-AAG y tanespimicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-10-15</DateLastModified></GlossaryTerm>
